These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 17700157

  • 1. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 2. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct 15; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 3. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May 15; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 4. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 6. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.
    Transplantation; 2004 Jan 15; 77(1):84-92. PubMed ID: 14724440
    [Abstract] [Full Text] [Related]

  • 7. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD, Lyden ER, Gulizia JM, McCashland TM.
    Liver Transpl; 2006 Jan 15; 12(1):134-9. PubMed ID: 16382465
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb 15; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 9. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.
    Liver Transpl; 2006 Apr 15; 12(4):560-5. PubMed ID: 16555313
    [Abstract] [Full Text] [Related]

  • 10. Donor age and outcome of liver transplantation.
    Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, Belle SH, Detre KM.
    Hepatology; 1996 Jul 15; 24(1):89-96. PubMed ID: 8707288
    [Abstract] [Full Text] [Related]

  • 11. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN.
    Liver Int; 2007 Aug 15; 27(6):758-63. PubMed ID: 17617118
    [Abstract] [Full Text] [Related]

  • 12. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr 15; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 13. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun 15; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 14. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.
    Liver Transpl; 2004 Oct 15; 10(10):1240-7. PubMed ID: 15376304
    [Abstract] [Full Text] [Related]

  • 15. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
    Selzner M, Kashfi A, Selzner N, McCluskey S, Greig PD, Cattral MS, Levy GA, Lilly L, Renner EL, Therapondos G, Adcock LE, Grant DR, McGilvray ID.
    Liver Transpl; 2009 Oct 15; 15(10):1288-95. PubMed ID: 19790152
    [Abstract] [Full Text] [Related]

  • 16. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, Edwards E, Taranto S, Johnson LB.
    Liver Transpl; 2001 Sep 15; 7(9):762-8. PubMed ID: 11552208
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R, Ruppert K, Cruz RJ, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes PA, de Vera ME.
    Liver Transpl; 2010 Nov 15; 16(11):1288-95. PubMed ID: 21031544
    [Abstract] [Full Text] [Related]

  • 18. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.
    Liver Transpl; 2009 Sep 15; 15(9):1063-71. PubMed ID: 19718647
    [Abstract] [Full Text] [Related]

  • 19. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
    Doyle MB, Anderson CD, Vachharajani N, Lowell JA, Shenoy S, Lisker-Melman M, Korenblat K, Crippin JS, Chapman WC.
    Arch Surg; 2008 Jul 15; 143(7):679-85; discussion 685. PubMed ID: 18645111
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.
    Liver Transpl; 2007 May 15; 13(5):687-92. PubMed ID: 17457911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.